home / stock / grts / grts news

GRTS News and Press, Gritstone Oncology Inc. From 11/12/19

Stock Information
Company Name: Gritstone Oncology Inc.
Stock Symbol: GRTS
Market: NASDAQ
Website: gritstonebio.com
Menu
GRTS GRTS Quote GRTS Short GRTS News GRTS Articles GRTS Message Board
Get GRTS Alerts

News, Short Squeeze, Breakout and More Instantly...
GRTS - Gritstone Oncology Reports Third Quarter 2019 Financial Results and Recent Highlights

EMERYVILLE, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported recent business highlights and financial results for ...
GRTS - Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy

-Poster Presentation at SITC 2019 Annual Meeting- EMERYVILLE, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announce...

GRTS - An Uber Exciting Week (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch ...

GRTS - Stocks To Watch: An Uber Exciting Week

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
GRTS - Gritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC Conference

EMERYVILLE, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that it will webcast an investor event with its execut...

GRTS - Gritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within "Off-The-Shelf" SLATE Immunotherapy at SITC 2019 Annual Meeting

EMERYVILLE, Calif., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that it will present the novel shared neoantigens in...

GRTS - Gritstone Oncology to Present at Cantor Global Healthcare Conference

EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Jean-Marc Bellemin, M.B.A., executive vice presi...
GRTS - Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones

EMERYVILLE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced changes to its board of directors. Elaine V. Jones,...

GRTS - Gritstone Oncology (GRTS) Presents At Biotechnology Conference - Slideshow

The following slide deck was published by Gritstone Oncology, Inc. in conjunction with this Read more ...

GRTS - Gritstone Oncology Announces First Patient Dosed with SLATE, its "Off-The-Shelf" Neoantigen Immunotherapy

EMERYVILLE, Calif., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of immunotherapies to fight multiple cancer types, today announced that the first SLATE patient has been dosed. SLATE is an in...
Previous 10 Next 10